Breast

Papers
(The H4-Index of Breast is 34. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
P280 How often do breast cancer patients seek traditional Chinese medicine in North China?2025
No association between breast pain and breast cancer201
Using Radio-Occult Lesion Localization (Roll) Techniques To Identify The Clipped Node In Targeted Axillary Dissections (Tad)159
SBRT AND NEW RADIOTHERAPY TECHNIQUES FOR METASTATIC DISEASE142
ADVANCED BREAST CANCER (ABC) PATIENT SUPPORT BY WEB CONFERENCING USING ZOOM113
A PATIENT’S JOURNEY: BRIDGING THE GAP FROM METASTATIC BREAST CANCER DIAGNOSIS TO ACTIVE INVOLVEMENT AS A PEER NAVIGATOR112
PO118 RESULTS OF ANTI-HER 2 THERAPIES AFTER BRAIN METASTASES ON THE PROGNOSIS IN BREAST CANCER PATIENTS91
PO120 CAN A BREAST CANCER REGISTER MEASURE ADHERENCE TO NATIONAL ADVANCED BREAST CANCER (ABC) TREATMENT GUIDELINES IN CLINICAL PRACTICE?85
Editorial Board78
SA 1.1 Surgery of patients with early breast cancer: Quo vadis?77
SA 9.1 Optimal neoadjuvant and adjuvant therapy for patients with early triple negative breast cancer67
P037 EGFR overexpression is related to immunohistochemical biomarkers in breast cancer64
P184 Unsatisfactory cosmetic results after oncoplastic breast-conserving surgery63
P203 Comparing the combine flap fixation and Harmonic scalpel technique with the Harmonic scalpel alone in reducing seroma formation after mastectomy in breast cancer patient: A pilot study for a RCT62
P098 Adjuvant radiotherapy after radical surgery and immediate breast reconstruction57
P152 The impact of the TailorX and RxPonder studies and the use of Oncotype Dx in clinical practice: A single Breast Cancer Center experience53
PO136 IMPACT OF ISOLATED SOLITARY BREAST CANCER LIVER METASTASIS SURGICAL RESECTION ON COMMON PATIENT HEALTH STATUS AND ABILITY TO PROCEED CHEMOTHERAPY48
Immediate breast reconstruction on overall and breast cancer-specific survival: A propensity score matched analysis47
P305: The SLIM Approach: Introducing a novelway for the orientation of cavity shaves during breast conserving surgery in breast cancer patients44
P149: Management of B3 breast lesions: clinical implications in light of the 2024 EUSOMA guidelines44
P243: Partnership Between Breast Oncology Surgical Services and Hyperbaric Oxygen Therapy Unit Reduces Complications And Improves Outcomes43
P332: Oncological Safety and Patient Satisfaction of Immediate Lipofilling in Breast-Conserving Surgery: A Systematic Reviewand Subgroup Meta-Analysis Comparing Outcomes with No Lipofilling42
P229: Impact of neoadjuvant chemotherapy on early relapses of luminal stage II breast cancer42
P287: The Clinical efficacy of the ICG Fluorescence injection technique with blue dye for sentinel lymph node biopsy using dual injection technique in early breast cancer patients40
P279: Evaluation of Pathologic Complete Response (pCR) as a Surrogate for Event-Free Survival in neoadjuvant Human Epidermal Growth Factor Receptor 2–Positive (HER2+) Early Breast Cancer (eBC)40
P309: Four Grounds for Choosing Bilateral Free DIEP Flap Breast Reconstruction in Breast Cancer with Large and Ptotic Breasts: a retrospective case-control study38
P473: Percutaneous Ultrasound-Guided Cryoablation for the Treatment of Breast Cancer in Non-Surgical Patients37
Optimising post-operative radiation therapy after oncoplastic and reconstructive procedures36
Serum sodium ions and chloride ions associated with taxane-induced peripheral neuropathy in Chinese patients with early-stage breast cancer: A nation-wide multicenter study36
The continuing conundrum in oligometastatic breast carcinoma: A real-world data36
Efficacy and safety of oncoplastic breast-conserving surgery versus conventional breast-conserving surgery: An updated meta-analysis35
Potential immune response to breast implants after immunization with COVID-19 vaccines35
Olaparib monotherapy in advanced triple-negative breast cancer patients with homologous recombination deficiency and without germline mutations in BRCA1/2: The NOBROLA phase 2 study34
Sarcopenia in patients with metastatic breast cancer: A systematic review and meta-analysis34
Enhancing clinical decision support with genomic tools in breast cancer: A Scottish perspective34
0.060810089111328